Acute changes in pulmonary blood flow (PBF) are an integral part of surgical repair of many congenital heart defects. In patients with single ventricle anatomy and physiology, the post-operative balance of blood flow to the lungs and body is often dictated by the resistances of the respective vascular beds. In fact, post-operatively the dynamic changes in vascular resistance can lead to significant morbidity and mortality, and much of our therapies are focused on altering pulmonary vascular resistance in attempt to optimize cardiac output while maintaining enough pulmonary flow to ensure adequate systemic oxygenation. In our initial project, we characterized novel chronic alterations and interactions in nitric oxide (NO) and endothelin-1 (ET-1) signaling during a model of increased PBF secondary to congenital heart disease in the lamb. We have recently demonstrated that NO and ET-1 may also acutely co-regulate each other, via a superoxide-dependent mechanism, and that these interactions mediate dynamic changes in vascular tone following acute changes in fetal PBF. Based on our preliminary data, we hypothesize that NO-ET-1 interactions mediate the dynamic changes in pulmonary vascular resistance immediately following surgically induced changes in PBF. In particular, we hypothesize that via ETA receptor signaling, superoxide-mediated decreases in NO activity and increased ET-l-induced vasoconstriction limit increases in PBF following surgery. In this renewal application, we will utilize an integrated physiologic, biochemical, cellular, and molecular approach to investigate this hypothesis and its mechanisms in 3 proposed Aims.
In Aim 1, we plan to indirectly investigate the effect of changes in PBF and pressure on NO and ET-1 gene expression and activity in clinically relevant whole animal models, and potential developmental differences.
In Aim 2, we will utilize whole animal models, smooth muscle cell cultures, and endothelial/smooth muscle cell co-cultures to investigate the effects of NO/ET-1 interactions in regulating changes in PBF and pressure, the potential role of reactive oxygen species in these interactions, and potential developmental differences.
In Aim 3, we will utilize whole animal models, endothelial cell cultures, and co-cultures to determine the independent effects of pressure vs. flow in this process. A better understanding of these mechanisms may improve perioperative treatment strategies and reduce morbidity and mortality.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL061284-05
Application #
6617676
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Berberich, Mary Anne
Project Start
1999-07-01
Project End
2008-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
5
Fiscal Year
2003
Total Cost
$463,405
Indirect Cost
Name
University of California San Francisco
Department
Pediatrics
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Balkin, Emily Morell; Zinter, Matt S; Rajagopal, Satish K et al. (2018) Intensive Care Mortality Prognostic Model for Pediatric Pulmonary Hypertension. Pediatr Crit Care Med 19:733-740
Morris, Catherine J; Kameny, Rebecca J; Boehme, Jason et al. (2018) KLF2-mediated disruption of PPAR-? signaling in lymphatic endothelial cells exposed to chronically increased pulmonary lymph flow. Am J Physiol Heart Circ Physiol 315:H173-H181
Black, Stephen M; Field-Ridley, Aida; Sharma, Shruti et al. (2017) Altered Carnitine Homeostasis in Children With Increased Pulmonary Blood Flow Due to Ventricular Septal Defects. Pediatr Crit Care Med 18:931-934
Rafikova, Olga; Meadows, Mary L; Kinchen, Jason M et al. (2016) Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung. PLoS One 11:e0150480
Datar, Sanjeev A; Gong, Wenhui; He, Youping et al. (2016) Disrupted NOS signaling in lymphatic endothelial cells exposed to chronically increased pulmonary lymph flow. Am J Physiol Heart Circ Physiol 311:H137-45
Oishi, Peter; Fineman, Jeffrey R (2016) Pulmonary Hypertension. Pediatr Crit Care Med 17:S140-5
Kameny, Rebecca Johnson; Fineman, Jeffrey R (2016) The Prescient Prognosticator? Hepatoma-derived Growth Factor in Pulmonary Hypertension. Am J Respir Crit Care Med 194:1186-1187
Boehme, Jason; Sun, Xutong; Tormos, Kathryn V et al. (2016) Pulmonary artery smooth muscle cell hyperproliferation and metabolic shift triggered by pulmonary overcirculation. Am J Physiol Heart Circ Physiol 311:H944-H957
Sun, Xutong; Kellner, Manuela; Desai, Ankit A et al. (2016) Asymmetric Dimethylarginine Stimulates Akt1 Phosphorylation via Heat Shock Protein 70-Facilitated Carboxyl-Terminal Modulator Protein Degradation in Pulmonary Arterial Endothelial Cells. Am J Respir Cell Mol Biol 55:275-87
Bertero, Thomas; Cottrill, Katherine A; Lu, Yu et al. (2015) Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit. Cell Rep 13:1016-32

Showing the most recent 10 out of 85 publications